Salazar discloses Goldman Sachs trade among $850K stock purchases

Maria Elvira Salazar’s latest disclosure put Goldman Sachs back in the political crosshairs, with the Florida Republican reporting a Goldman trade alongside roughly $850,000 in stock activity across 24 names. The filing landed as Wall Street names were rallying, turning a routine transaction report into another test of whether congressional trading looks like confidence, coincidence, or conflict.

The House financial transaction report, filed April 1, 2026, shows two Goldman Sachs transactions dated March 19, 2026: a purchase in Salazar’s UBS brokerage account valued at $15,001 to $50,000, and a sale in her UBS IRA account in the same range. That means the public filing is not a simple buy list. It captures both sides of the trade, which makes the Goldman entry harder to read as a clean bet on the bank’s shares.

Salazar’s filing also covered Amgen, Boeing, Cisco, Citigroup, Corning, FedEx, GE Aerospace, Honeywell, NVR, Peloton, RH, Ulta Beauty, United Rentals, Venture Global and Whirlpool, showing a broad portfolio of individual names rather than a one-off position. MarketBeat’s congressional trading tracker puts her disclosed trading volume at about $846,500 across 22 trades and 13 companies, underscoring that this was part of an active pattern rather than an isolated move.

The disclosure arrives under the STOCK Act, which requires lawmakers to publicly report financial transactions within 45 days. That deadline has kept congressional stock trading under a microscope in Washington, where bipartisan efforts to ban lawmakers from trading stocks have resurfaced repeatedly. Axios reported renewed pushes in 2024 and 2025, with support from activists and lawmakers on both sides of the aisle.

For Goldman, the optics matter. The firm reported full-year 2025 net revenues of $58.28 billion and net earnings of $17.18 billion on Jan. 15, 2026, and its 2026 outlook materials projected global stocks could return 11% over the next 12 months. In that context, a sitting lawmaker’s Goldman trade becomes more than a filing detail. It reads as a small but visible vote of confidence in a name that still carries weight in New York, on trading desks, and in Washington.

That is why the disclosure is likely to draw attention well beyond Salazar’s district. At a moment when congressional trading remains a live ethics fight, a Goldman transaction does not just reflect one member’s portfolio. It turns the firm into a proxy for the broader argument over whether lawmakers should be allowed to trade the same market-sensitive names they help regulate.